Max Hodak on BCI: Sensory Inputs Beat Hand Substitutes
Max Hodak explains why Science Corporation targets high-bandwidth sensory input over brain keyboards limited by a 10-bit bottleneck.
From Restoring Sight to Reimagining the Brain, with Max Hodak
With Sarah Guo, Max Hodak · Sunday, August 23, 2026
Max Hodak, co-founder and CEO of Science Corporation, joins Sarah Guo to discuss PRIMA, Science's retinal implant that restores functional form vision to blind patients and recently gained CE mark approval in Europe. Hodak outlines his philosophy of treating the brain as a computational system rather than relying solely on traditional pharmaceutical drug discovery. He also explores the Platonic representation hypothesis in AI, the importance of phenomenal continuity in brain emulation, and Science's long-term vision of substrate independence and reducing biological fragility.
Why Science Corporation Treats the Brain Like Hardware
Max Hodak explains why neural interfaces beat 10-year drug discovery cycles by treating the brain as a computational system.
Max Hodak: Why Digital Brain Clones Miss Consciousness
Max Hodak explains why digital copies fail consciousness and how connectomics enables real substrate independence.
How Science Corporation Restored Form Vision with PRIMA
Science Corporation's PRIMA implant restores form vision to blind patients. Max Hodak explains the hardware, clinical trials, and European approval.
Max Hodak on Brain-Centric Medicine and Human Fragility
Max Hodak explains why Science Corporation treats the brain as the only indispensable organ and views the body as replaceable support hardware.
AI Models and Biological Brains Share the Same Geometry
Max Hodak explains why AI latent spaces match animal brain recordings and what model convergence means for neurotech.